YOLFTbeta
K0

Adicon Holdings Limited

K0U · F · Healthcare / Diagnostics & Research

0.484EUR+0.02 (+5.22%)

Price History

Full chart

Market Stats

Previous Close0.46
Open0.484
Day Range0.484 – 0.484
52-Week Range0.334 – 0.61
Volume0
Market Cap361.31M
P/E (TTM)0.00
Forward P/E23.31
EPS0.00
Dividend Yield0.00%
Beta0.26
50-Day Avg0.3979
200-Day Avg0.4413

About

Adicon Holdings Limited, an investment holding company, provides medical testing services in the People's Republic of China. The company offers testing services primarily to hospitals and health check centers through an integrated network of self-operated laboratories; and research and clinical trial services. It is also involved in the trading of medical testing equipment. The company was founded in 2004 and is headquartered in Hangzhou, the People's Republic of China.

Company Details

  • SectorHealthcare
  • IndustryDiagnostics & Research
  • CEOMr. Legang Wang
  • Employees5.02K
  • HeadquartersNo. 208, Zhenzhong Road, Hangzhou, China, Germany
  • Websitehttps://www.adicon.com.cn

Leadership

  • Mr. Legang WangCOO, Interim CEO, GM & Executive Director · b. 1981
  • Mr. Lawrence Allen Wang M.B.A., M.D.CFO, Senior VP & Joint Company Secretary · b. 1977
  • Mr. Jianing ChuVP and Chief Strategy & Compliance Officer · b. 1981
  • Mr. Shun GeVP & Chief Marketing Officer · b. 1975
  • Mr. Chao PanSenior VP & Head of Laboratory · b. 1964
  • Ms. Lai Wah LeeJoint Company Secretary

Financials

Income Statement

Currency: CNY2021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue3.38B4.86B3.30B2.91B2.64B
Growth (%)-+43.83%-32.15%-11.64%-9.46%
Cost of Revenue1.94B2.96B1.86B1.82B1.69B
Gross Profit1.44B1.90B1.43B1.10B952.48M
Gross Margin42.68%39.01%43.49%37.70%36.10%
Operating Expense907.98M992.03M951.86M827.43M795.17M
Operating Income534.41M904.14M482.25M271.22M157.31M
Operating Margin15.81%18.60%14.62%9.31%5.96%
EBITDA-1.08B603.13M320.41M285.21M
EBITDA Margin-22.17%18.29%11.00%10.81%
Net Income315.54M680.79M234.88M47.01M18.44M
Net Income Margin9.34%14.01%7.12%1.61%0.70%
R&D125.45M162.75M143.52M120.04M103.67M
R&D as % of Total Revenue3.71%3.35%4.35%4.12%3.93%
Interest Expense16.33M63.37M86.32M52.36M48.51M
Interest Expense % of Total Revenue0.48%1.30%2.62%1.80%1.84%

Balance Sheet

Currency: CNY2021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets3.11B4.85B4.55B4.69B4.80B
Total Liabilities2.26B4.24B2.72B2.91B2.95B
Total Equity804.24M510.82M1.71B1.65B1.72B
Cash1.11B1.68B959.42M1.04B170.97M
Net Debt---262.08M1.30B

Cash Flow

Currency: CNY2021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow564.26M892.94M377.54M230.44M225.74M
Capital Expenditure156.12M297.36M165.45M117.58M108.25M
Free Cash Flow408.14M595.58M212.09M112.86M117.49M
Dividends Paid452.58M865.02M---
FCF to OCF72.33%66.70%56.18%48.98%52.05%
Dividend Paid to FCF110.89%145.24%---

Key Statistics & Ratios

Market Cap361.31M
Enterprise Value414.34M
Trailing P/E0.00
Forward P/E23.31
PEG Ratio0.41
Price / Sales0.14
Price / Book1.26
EPS0.00
Book Value0.3172
Revenue (TTM)2.65B
Gross Profit (TTM)985.32M
EBITDA277.61M
Profit Margin0.87%
Operating Margin5.70%
Return on Equity1.62%
Return on Assets2.10%
Shares Outstanding715.47M
Shares Float234.11M
Beta0.26
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%